Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Health and Quality of Life Outcomes
|
February 15, 2017
Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire
Rosalie E Ferner, Mary Thomas, Gemma Mercer, et al.
BMJ Neurology Open
|
May 31, 2024
Treating benign paroxysmal positional vertigo in acute traumatic brain injury: a prospective, randomised clinical trial assessing safety, feasibility, and efficacy
Rebecca M Smith, Caroline Burgess, Jenna Beattie, et al.
Plos One
|
September 19, 2014
Visual dependency and dizziness after vestibular neuritis
Sian Cousins, Nicholas J Cutfield, Diego Kaski, et al.
Lancet (London, England)
|
November 21, 2016
Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial
Mitesh Patel, Kiran Agarwal, Qadeer Arshad, et al.
Journal of Neurological Surgery. Part B, Skull Base
|
April 2, 2013
The NFTI-QOL: A Disease-Specific Quality of Life Questionnaire for Neurofibromatosis 2
Rachael E Hornigold, John F Golding, Guy Leschziner, et al.
Journal of Vestibular Research : Equilibrium & Orientation
|
March 1, 2021
Motion sickness diagnostic criteria: Consensus Document of the Classification Committee of the Bárány Society
Yoon-Hee Cha, John F Golding, Behrang Keshavarz, et al.
Journal of Neurology
|
March 13, 2014
Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2
Rosalie E Ferner, Adam Shaw, D Gareth Evans, et al.
Neuro-Oncology Practice
|
April 26, 2018
Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation
Katrina A Morris, John F Golding, Patrick R Axon, et al.
Brain : a Journal of Neurology
|
February 14, 2019
Abnormal visuo-vestibular interactions in vestibular migraine: a cross sectional study
Nadja F Bednarczuk, Angela Bonsu, Marta Casanovas Ortega, et al.
Journal of Neuro-Oncology
|
November 1, 2016
Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort
Katrina A Morris, John F Golding, Claire Blesing, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Health and Quality of Life Outcomes
|
February 15, 2017
Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire
Rosalie E Ferner, Mary Thomas, Gemma Mercer, et al.
BMJ Neurology Open
|
May 31, 2024
Treating benign paroxysmal positional vertigo in acute traumatic brain injury: a prospective, randomised clinical trial assessing safety, feasibility, and efficacy
Rebecca M Smith, Caroline Burgess, Jenna Beattie, et al.
Plos One
|
September 19, 2014
Visual dependency and dizziness after vestibular neuritis
Sian Cousins, Nicholas J Cutfield, Diego Kaski, et al.
Lancet (London, England)
|
November 21, 2016
Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial
Mitesh Patel, Kiran Agarwal, Qadeer Arshad, et al.
Journal of Neurological Surgery. Part B, Skull Base
|
April 2, 2013
The NFTI-QOL: A Disease-Specific Quality of Life Questionnaire for Neurofibromatosis 2
Rachael E Hornigold, John F Golding, Guy Leschziner, et al.
Journal of Vestibular Research : Equilibrium & Orientation
|
March 1, 2021
Motion sickness diagnostic criteria: Consensus Document of the Classification Committee of the Bárány Society
Yoon-Hee Cha, John F Golding, Behrang Keshavarz, et al.
Journal of Neurology
|
March 13, 2014
Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2
Rosalie E Ferner, Adam Shaw, D Gareth Evans, et al.
Neuro-Oncology Practice
|
April 26, 2018
Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation
Katrina A Morris, John F Golding, Patrick R Axon, et al.
Brain : a Journal of Neurology
|
February 14, 2019
Abnormal visuo-vestibular interactions in vestibular migraine: a cross sectional study
Nadja F Bednarczuk, Angela Bonsu, Marta Casanovas Ortega, et al.
Journal of Neuro-Oncology
|
November 1, 2016
Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort
Katrina A Morris, John F Golding, Claire Blesing, et al.
Page
of 5